Stay updated on Vibecotamab in MRD+ AML/MDS Clinical Trial
Sign up to get notified when there's something new on the Vibecotamab in MRD+ AML/MDS Clinical Trial page.

Latest updates to the Vibecotamab in MRD+ AML/MDS Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page history shows an addition of a software revision entry v3.4.2 and a deletion of v3.4.1, which appear to be internal site version updates and do not alter study data or visible page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedThe page history shows a new revision entry (v3.4.1) and removal of an earlier revision (v3.4.0). These are minor metadata updates to the page that do not affect study data or user-facing functionality; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedUI text updates include a Show glossary option, color-coded legends for additions and deletions, and an updated Revision: v3.4.0, with minor wording/capitalization tweaks (e.g., No FEAR Act Data). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check42 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3 from the study record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a page revision note 'Revision: v3.3.3' to the history list and removed the 'HHS Vulnerability Disclosure' and the previous 'Revision: v3.3.2' entry from the footer. These are administrative updates that do not affect study data or user actions.SummaryDifference0.2%

- Check91 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed from the page history, reflecting a routine software update.SummaryDifference0.1%

Stay in the know with updates to Vibecotamab in MRD+ AML/MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vibecotamab in MRD+ AML/MDS Clinical Trial page.